Search

everythinglearnresearchcommunity

for

Search:↓

Low-cost dermoscopes can effectively diagnose early female pattern hair loss.

Treatment improved some symptoms but not all.

The patient has frontal fibrosing alopecia (FFA).

Hair transplantation successfully treated hair loss in a patient with Trichorhinophalangeal syndrome.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Botulinum toxin treatment improves hair follicle width and length in androgenetic alopecia.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

Certain genes and proteins may help diagnose and treat primary cicatricial alopecia.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

A specific mutation in the K25 gene causes a rare genetic disorder with curly hair at birth and later hair loss, along with dental issues.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Trichoscopy is useful for diagnosing hair and scalp disorders in people with darker skin.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

Hair density and thickness decrease in specific scalp areas in people with androgenetic alopecia.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Hair transplants can work for stable cicatricial alopecia, but success varies by condition.

Lichen planus on the scalp can cause scarring hair loss and has four main types.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Myotonic dystrophy may be classified as a segmental progeroid disorder.

MicroRNAs may help diagnose and treat hair loss disorders.

New genetic mutations linked to rare skin disorders were found in three newborns.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Primary cicatricial alopecia is linked to various health issues, indicating broader systemic problems.

Combining treatments works best for early hair loss, while transplants are best for severe cases.

Men's and women's pattern hair loss progress differently, with men showing more hair thinning and women having more widespread hair loss.